Sitemap
- Home
- About Us
- EQA/PT Programmes
- New Participant Information
- Flow Cytometry Programmes
- CD34+ Stem Cell Enumeration
- Cerebrospinal Fluid (CSF) Immunophenotyping (Not Accredited)
- Haematological Malignancy Bone Marrow Aspirate Assessment (Not Accredited)
- Immune Monitoring
- Immune Monitoring (Alternative Technologies)
- Leukaemia Immunophenotyping (Part 1)
- Leukaemia Diagnostic Interpretation (Part 2)
- Low Level Leucocyte Enumeration
- Minimal Residual Disease for Plasma Cell Myeloma by Flow Cytometry (Not Accredited)
- Minimal Residual Disease for ALL by Flow Cytometry
- Minimal Residual Disease for AML by Flow Cytometry (Not Accredited)
- Minimal Residual Disease for CLL by Flow Cytometry (Not Accredited)
- Paroxysmal Nocturnal Haemoglobinuria
- Veriqas™ Panel
- Molecular Genetics Programmes
- Acute Myeloid Leukaemia Gene Panels (Not Accredited)
- BCR-ABL1 and AML Translocation Identification
- BCR-ABL1 Kinase Domain Mutation Status (Not Accredited)
- BCR-ABL1 Major Quantification
- BCR-ABL1 Minor Quantification (Not Accredited)
- BRAF p.Val600Glu (V600E) Mutation Status for Hairy Cell Leukaemia
- FLT3 Mutation Status
- IgH/TCR Clonality Status
- JAK2 p.Val617Phe (V617F) Mutation Status
- KIT p.Asp816Val (D816V) Mutation Status for Mast Cell Disease
- NPM1 Mutation Status
- Myeloproliferative Neoplasm Gene Panels (Not Accredited)
- Paediatric Acute Leukaemia Translocations
- Post-Stem Cell Transplant Chimerism Monitoring
- News/Events
- Contact us
Print
Sitemap
Follow Us Online!
Facebook Twitter LinkedIn Youtube
Last updated 21st November 2017 © UK NEQAS for Leucocyte Immunophenotyping not to be reproduced in all or part without permission.
This website uses cookies. For more information, please click here.
The UK NEQAS Organisation is a Company Limited by Guarantee (No.3012351) and a Registered UK Charity (No.1044013).